Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
The levels of other parameters: estradiol, prolactin, 17-OH-progesterone, LH, FSH, SHBG, testosterone, BAT%, FAI%, androstendione, vitamin D, calcitonin, parathyroid hormone, osteoprotegerin, sRANKLt, leptin, BMD total, BMD L1-L4, T-score, Z-score, BMI, BMC, AG, TBS and glucose in women with hyperandrogenism in relation to the distribution of genotypes of the ESR1 rs3020314 polymorphism did not show any significant statistical differences.Analysis of hormonal parameters in relation to ESR1 gene polymorphisms in patients with hyperandrogenism.ParameterESR1 rs3020314Mean ± SEMPESR1 rs2077647Mean ± SEMPESR1 rs1884051Mean ± SEMPTestosterone (ng/ml)CC0.53 ± 0.050.821CC0.39 ± 0.040.114AA0.49 ± 0.040.815CT0.50 ± 0.05CT0.54 ± 0.04AG0.47 ± 0.05TT0.47 ± 0.04TT0.50 ± 0.06GG0.53 ± 0.05BAI %CC42.93 ± 6.010.973CC46.00 ± 3.550.198AA42.45 ± 2.500.987CT41.83 ± 2.70CT43.25 ± 2.44AG42.01 ± 2.72TT42.61 ± 2.54TT37.62 ± 3.40GG42.93 ± 6.01FAI %CC1.83 ± 0.260.974CC1.96 ± 0.150.199AA1.81 ± 0.110.987CT1.78 ± 0.12CT1.84 ± 0.10AG1.79 ± 0.12TT1.82 ± 0.11TT1.60 ± 0.15GG1.83 ± 0.26Androstendione (ng/ml)CC5.43 ± 0.890.087CC3.55 ± 0.480.420AA3.90 ± 0.310.096CT3.10 ± 0.29CT4.23 ± 0.33AG3.86 ± 0.30TT3.79 ± 0.31TT4.19 ± 0.36GG5.43 ± 0.89DHEA-SO4 (μg/dl)CC332.80 ± 69.440.280CC203.02 ± 28.430.018AA244.76 ± 23.080.293CT274.65 ± 25.94CT314.72 ± 24.92AG274.00 ± 27.13TT243.46 ± 23.73TT233.54 ± 32.64GG332.80 ± 69.44SHBG (nmol/l)CC54.15 ± 27.510.642CC33.95 ± 5.200.276AA40.57 ± 4.200.663CT42.99 ± 7.26CT40.91 ± 6.92AG42.30 ± 7.64TT39.97 ± 4.21TT53.30 ± 9.79GG54.15 ± 27.51BAI% Body Adiposity Index, FAI% Free Androgen Index, DHEA-SO4 dehydroepiandrosterone sulfate, SHGB sex hormone binding globulin.Significant values are given in bold.Analysis of bone metabolism parameters in relation to ESR1 gene polymorphisms in patients with hyperandrogenism.ParamaterESR1 rs30220314Mean ± SEMPESR1 rs2077647Mean ± SEMPESR1 rs1884051Mean ± SEMPVitamin D (ng/ml)CC8.67 ± 4.330.591CC14.4 ± 3.110.266AA15.90 ± 1.790.602CT15.47 ± 3.60CT13.79 ± 2.01AG16.14 ± 3.92TT16.20 ± 1.84TT19.89 ± 3.73GG8.67 ± 4.3325(OH)D (ng/ml)CC25.17 ± 3.600.241CC18.62 ± 1.430.002AA20.63 ± 1.080.279CT22.21 ± 1.23CT20.90 ± 1.13AG22.56 ± 1.27TT20.64 ± 1.13TT26.23 ± 1.68GG24.78 ± 4.06Calcitonin (pg/ml)CC1.57 ± 0.440.797CC4.22 ± 2.910.267AA2.61 ± 1.320.841CT1.77 ± 0.27CT1.78 ± 0.22AG1.80 ± 0.28TT2.69 ± 1.39TT1.19 ± 0.19GG1.65 ± 0.50PTH (pg/ml)CC39.86 ± 4.010.289CC41.03 ± 5.930.635AA43.70 ± 4.040.392CT35.75 ± 3.18CT42.30 ± 3.61AG36.48 ± 3.21TT44.22 ± 4.17TT36.48 ± 3.70GG38.35 ± 4.21OPG (pmol/l)CC3.48 ± 0.370.638CC3.32 ± 0.150.477AA3.69 ± 0.210.879CT3.48 ± 0.23CT3.71 ± 0.25AG3.53 ± 0.24TT3.76 ± 0.22TT3.75 ± 0.30GG3.60 ± 0.40sRANKL (pmol/l)CC255.48 ± 97.980.394CC227.68 ± 46.100.487AA189.73 ± 15.470.389CT240.61 ± 41.41CT190.27 ± 18.60AG240.08 ± 42.96TT188.10 ± 16.17TT248.46 ± 54.89GG263.90 ± 110.68Leptin (ng/ml)CC16.84 ± 4.240.379CC24.86 ± 4.320.420AA22.35 ± 2.430.555CT24.89 ± 2.68CT23.43 ± 2.20AG24.33 ± 2.81TT22.19 ± 2.54TT18.91 ± 3.07GG17.69 ± 4.7125(OH)D 25-OH vitamin D, PTH Parathormon, OPG osteoprotegerin, sRANKL soluble receptor activator of nuclear factor-kB ligand.Significant values are given in bold.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The study was conducted from 2013 to 2015, consisted of 80 young women aged 18 to 35 with hyperandrogenism, attending the Department of Endocrinology, Metabolic Diseases, and Internal Diseases, at the Pomeranian Medical University in Szczecin (Poland).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
The influence of ESR1 polymorphisms on selected hormonal, metabolic and mineral balance markers in women with hyperandrogenism
Study design awaiting verification · Scientific Reports · 2022
Original publication title
The influence of ESR1 polymorphisms on selected hormonal, metabolic and mineral balance markers in women with hyperandrogenism
© The Author(s) 2022
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Hyperandrogenism is the most common endocrine disorder in women, characterized by an imbalance in normal estrogen and androgen levels in the blood. Androgens influence bone mineral density, body mass composition, muscle mass, mental state, and the regulation of sexual function.. The aim of the study was to assess the effect of estrogen receptor α gene (ESR1) polymorphisms on selected markers of bone metabolism and hormonal parameters in women with hyperandrogenism. The study group included 80 young women with hyperandrogenism who underwent measurements of bone mineral density (BMD), and determination of hormonal and metabolic parameters.
Enzyme immunoassays were used to measure leptin, sRANKL (soluble receptor activator of nuclear factor-kB ligand), osteoprotegerin and 25-OH vitamin D total levels. An analysis of ESR1 gene polymorphisms was performed using the real-time PCR method. A relationship was demonstrated between the concentration of free estradiol (FEI) and the concentration of 17-OH-progesterone, and the ESR1 gene polymorphisms: rs3020314 (p = 0.031, p = 0.026 respectively) and rs1884051 (p = 0.033, p = 0.026 respectively). In conclusion, the ESR gene polymorphisms may be associated with hormonal disturbances in the concentration of estrogens and androgens, in hyperandrogenism in young women which may indirectly affect bone mineral density.
However, no statistically significant relationships between the studied polymorphisms and the selected parameters of mineral metabolism have been demonstrated..
Authors’ abstract
Hyperandrogenism is the most common endocrine disorder in women, characterized by an imbalance in normal estrogen and androgen levels in the blood. Androgens influence bone mineral density, body mass composition, muscle mass, mental state, and the regulation of sexual function.. The aim of the study was to assess the effect of estrogen receptor α gene (ESR1) polymorphisms on selected markers of bone metabolism and hormonal parameters in women with hyperandrogenism. The study group included 80 young women with hyperandrogenism who underwent measurements of bone mineral density (BMD), and determination of hormonal and metabolic parameters.
Enzyme immunoassays were used to measure leptin, sRANKL (soluble receptor activator of nuclear factor-kB ligand), osteoprotegerin and 25-OH vitamin D total levels. An analysis of ESR1 gene polymorphisms was performed using the real-time PCR method. A relationship was demonstrated between the concentration of free estradiol (FEI) and the concentration of 17-OH-progesterone, and the ESR1 gene polymorphisms: rs3020314 (p = 0.031, p = 0.026 respectively) and rs1884051 (p = 0.033, p = 0.026 respectively). In conclusion, the ESR gene polymorphisms may be associated with hormonal disturbances in the concentration of estrogens and androgens, in hyperandrogenism in young women which may indirectly affect bone mineral density.
However, no statistically significant relationships between the studied polymorphisms and the selected parameters of mineral metabolism have been demonstrated..
Publication and source details
Original title: The influence of ESR1 polymorphisms on selected hormonal, metabolic and mineral balance markers in women with hyperandrogenism
Izabela Uzar; Anna Bogacz; Elżbieta Sowińska-Przepiera; Katarzyna Kotrych; Marlena Wolek; Tadeusz Sulikowski; Adam Kamiński
Scientific Reports · 2022
© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T08:35:19.394149+00:00
DOI: 10.1038/s41598-022-17383-w · PMC9668905